Reposar, Jhon Rey B.
HRN: 07-39-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/13/2023
02/19/2023
IVT
400mg
Od
Sepsis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes